| scholarly article | Q13442814 |
| P356 | DOI | 10.1002/PATH.2357 |
| P698 | PubMed publication ID | 18498093 |
| P50 | author | Judith C Sluimer | Q40504181 |
| Mat J A P Daemen | Q73172570 | ||
| P2093 | author name string | H van Goor | |
| A Michaud | |||
| S Heeneman | |||
| P Corvol | |||
| L H van den Akker | |||
| J M Gasc | |||
| J Cleutjens | |||
| A P J J Bijnens | |||
| B Jütten | |||
| I Hamming | |||
| P2860 | cites work | A novel angiotensin-converting enzyme-related carboxypeptidase (ACE2) converts angiotensin I to angiotensin 1-9 | Q24290169 |
| Lessons from sudden coronary death: a comprehensive morphological classification scheme for atherosclerotic lesions | Q33916802 | ||
| Membrane-associated zinc peptidase families: comparing ACE and ACE2. | Q36212498 | ||
| P433 | issue | 3 | |
| P921 | main subject | atherosclerosis | Q12252367 |
| P304 | page(s) | 273-279 | |
| P577 | publication date | 2008-07-01 | |
| P1433 | published in | Journal of Pathology | Q400296 |
| P1476 | title | Angiotensin-converting enzyme 2 (ACE2) expression and activity in human carotid atherosclerotic lesions | |
| P478 | volume | 215 |
| Q50464178 | ACE2 activity was increased in atherosclerotic plaque by losartan: Possible relation to anti-atherosclerosis |
| Q97537127 | Addressing male sexual and reproductive health in the wake of COVID-19 outbreak |
| Q55465043 | Advances in the renin angiotensin system focus on angiotensin-converting enzyme 2 and angiotensin-(1-7). |
| Q33443452 | Angiotensin II reduces membranous angiotensin-converting enzyme 2 in pressurized human aortic endothelial cells |
| Q52354923 | Angiotensin-(1-7) and Alamandine on Experimental Models of Hypertension and Atherosclerosis. |
| Q38193206 | Angiotensin-(1-7) and angiotensin-(1-9): function in cardiac and vascular remodelling |
| Q42554373 | Angiotensin-Converting Enzyme 2 (ACE2) Is a Key Modulator of the Renin Angiotensin System in Health and Disease |
| Q38207841 | Angiotensin-converting enzyme 2 and angiotensin 1-7: novel therapeutic targets |
| Q34912847 | Angiotensin-converting enzyme 2 deficiency in whole body or bone marrow-derived cells increases atherosclerosis in low-density lipoprotein receptor-/- mice |
| Q37155907 | Angiotensin-converting enzyme 2 in the brain: properties and future directions |
| Q34423315 | Angiotensin-converting enzymes and drug discovery in cardiovascular diseases. |
| Q98947021 | COVID-19 and possible links with Parkinson's disease and parkinsonism: from bench to bedside |
| Q93182046 | COVID-19 pathophysiology: A review |
| Q37634390 | Contrast enhanced ultrasound imaging |
| Q41572699 | Diminazene enhances stability of atherosclerotic plaques in ApoE-deficient mice. |
| Q55409649 | Elevated plasma angiotensin converting enzyme 2 activity is an independent predictor of major adverse cardiac events in patients with obstructive coronary artery disease. |
| Q38083745 | Emerging markers in cardiovascular disease: where does angiotensin-converting enzyme 2 fit in? |
| Q33795353 | From gene to protein-experimental and clinical studies of ACE2 in blood pressure control and arterial hypertension |
| Q35023822 | Gender differences in cardiovascular disease: hormonal and biochemical influences. |
| Q42700512 | Hydrogen Sulfide Attenuates Atherosclerosis in a Partially Ligated Carotid Artery Mouse model via Regulating Angiotensin Converting Enzyme 2 Expression |
| Q51632087 | Imbalance between angiotensin II and angiotensin-(1-7) in human coronary atherosclerosis. |
| Q94502928 | Manipulating angiotensin metabolism with angiotensin converting enzyme 2 (ACE2) in heart failure |
| Q39811943 | Potential enhancement of osteoclastogenesis by severe acute respiratory syndrome coronavirus 3a/X1 protein |
| Q38069197 | Regulation of cardiovascular remodeling by the counter-regulatory axis of the renin-angiotensin system |
| Q92268563 | Relationship between circulating levels of angiotensin-converting enzyme 2-angiotensin-(1-7)-MAS axis and coronary heart disease |
| Q38170474 | Role of angiotensin-converting enzyme 2 (ACE2) in diabetic cardiovascular complications. |
| Q38046618 | The ACE2 gene: its potential as a functional candidate for cardiovascular disease. |
| Q104576047 | Trained immunity as a novel approach against COVID-19 with a focus on Bacillus Calmette-Guérin vaccine: mechanisms, challenges and perspectives |
| Q42410684 | Vascular angiotensin-converting enzyme 2: lord of the ring? |
| Q101214896 | miR-98 Regulates TMPRSS2 Expression in Human Endothelial Cells: Key Implications for COVID-19 |
Search more.